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Summary
Background The rising incidence rates of skin cancer (SC) lead to an enormous
burden on healthcare systems. General practitioners (GPs) might play an impor-
tant part in SC care, but research has shown poor clinical recognition of SC, lead-
ing to a high rate of potentially unnecessary referrals.
Objectives The aim of this study was to evaluate if a dermato-oncological training pro-
gramme (DOTP) for GPs improved their diagnostic skills and quality of referrals.
Methods Out of 194 GPs in the Nijmegen area, 83 (428%) followed a DOTP on
SC. Referrals from both a trained cohort (TC) and two cohorts of untrained GPs
[untrained present cohort (UPC) and untrained historical cohort (UHC)] were
included. Data on diagnostic skills, quality of referrals and the number of poten-
tially unnecessary referrals were evaluated.
Results A total number of 1662 referrals were analysed. The referral diagnosis was
correct more often in the TC (703%) compared with the UPC (562%; P < 0001)
and the UHC (516%; P < 0001). Furthermore, the TC also provided a better lesion
description, mentioned a diagnosis more often in their referral letters and more
often performed diagnostics before referral. In addition, fewer potentially unneces-
sary referrals were identified in the TC compared with the UPC (627% vs. 737%;
P < 0001) and the UHC (752%; P < 0001).
Conclusions GPs who followed a DOTP had better diagnostic skills and quality of
referrals than untrained GPs, leading to fewer potentially unnecessary referrals.
This might enhance a more efficient use of the limited capacity in secondary der-
matological care and consequently lead to lower healthcare costs.
What is already known about this topic?
• General practitioners (GPs) play an important part in skin cancer (SC) care and
optimal recognition and referral are considered of vital importance to optimize SC
care efficacy.
• Previous research identified a rather poor clinical recognition of (pre)malignant
skin tumours by GPs, leading to a high rate of potentially unnecessary referrals to
dermatologists.
What does this study add?
• GPs who followed a dedicated dermato-oncological training programme had better
diagnostic skills and quality of referrals than untrained GPs, leading to fewer
potentially unnecessary referrals.
• This might enhance a more efficient use of the limited capacity in secondary der-
matological care and consequently lead to lower healthcare costs.
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Skin cancer (SC) is the most common malignancy worldwide
and the incidence rates are rapidly rising, leading to an enor-
mous and growing burden on healthcare systems.1–4 Most
patients with SC initially visit a general practitioner (GP),
often followed by referral to a dermatologist. Therefore, GPs
play an important part in SC care and optimal recognition and
referral are considered of vital importance to optimize efficacy
in SC care. Previous research identified a rather poor clinical
recognition of (pre)malignant skin tumours by GPs, leading to
a high rate of potentially unnecessary referrals.5 As previously
suggested, better training of GPs might improve their diagnos-
tic skills, diminish the number of potentially unnecessary
referrals and thereby optimize efficacy in SC care.6–9 The aim
of this study was to evaluate if a dedicated dermato-oncologi-
cal training programme (DOTP) for GPs improves the diag-
nostic skills and quality of referrals by GPs.
Materials and methods
In this cohort study, we studied the effect of a DOTP on the
diagnostic skills and quality of referrals by GPs.
The dermato-oncological training programme
A DOTP was developed as part of a project called ‘Suspicious
Skin Lesions’ in the Nijmegen area of the Netherlands. The
aim of this project was to improve SC care by GPs and transfer
low-risk nonmelanoma SC care to primary care, while main-
taining high-quality care. Previous research showed GPs and
dermatologists to be generally positive about this transfer of
care.9 At the beginning of the project, regional guidelines
were drawn up concerning the diagnostics and treatment of
(pre)malignant skin lesions in primary care, and when a GP
should refer a patient to a dermatologist (Appendix S1; see
Supporting Information). These regional guidelines were
based on existing (inter)national guidelines.10–15 The DOTP
consisted of: (1) instruction on the project (aims) and guide-
lines; (2) a mandatory online course on SC (including an
examination); and (3) two optional live courses on SC and
dermoscopy. The mandatory online course is a nationally
developed course on SC, developed by the Dutch College of
General Practitioners (NHG) together with SC experts,16
including sections on diagnostics (including punch biopsy),
therapy and counselling of patients regarding SC care and pre-
vention. The duration of this course was approximately 2 h.
Study population
All GPs with their own practice in the Nijmegen area (n =
194) received an invitation to participate in the project. In
total, 83 GPs (428%) participated in the project and finished
the DOTP, following the above-mentioned criteria. Of these,
46 (554%) and 21 (253%) finished the optional SC and der-
moscopy course, respectively, as well. Referrals from GPs to
dermatologists in two hospitals in the Nijmegen area
(Radboud University Medical Centre and Canisius-Wilhelmina
hospital) were included chronologically in two different time
periods after the DOTP was finished (September–October
2018 and May–June 2019). For comparison, referrals from
both trained and untrained GPs were included, forming a
trained cohort (TC) and an untrained present cohort (UPC).
Referrals in these two time periods were included to study the
sustainability of the effect of the DOTP over time. In addition,
a comparison was made using a historical control group from
previous research on GP referrals in the same population
(2008–2010),5 forming an untrained historical cohort (UHC).
The following referrals were excluded: referrals by GPs in
training under supervision by a GP who participated in the
project, and referrals by locum GPs (some locum GPs partici-
pated in the courses, but could not participate in the project;
therefore data could not be obtained). In addition, nine
trained GPs were excluded because although they followed the
obligatory part of the DOTP, they did not consent to further
participation (also shown in Figure 1).
Study outcomes and data collection
Firstly, the agreement between the referral diagnosis made by
GPs (primary diagnosis mentioned in the referral letter) and
the final diagnosis made by the dermatologist was assessed. In
cases in which no diagnosis was mentioned in the referral let-
ter, letters were excluded from this specific analysis. When
available, a histopathological diagnosis was used as the final
diagnosis. In cases of no histopathological diagnosis, the clini-
cal diagnosis made by the dermatologist was used as the final
diagnosis. In addition, the positive predictive values were also
assessed by comparing the full differential diagnosis provided
by GPs in the referral letter with the final diagnosis made by
the dermatologist.
Secondary outcomes were: (1) the proportion of proper
dermatological descriptions used in the referral letters; (2) the
number of diagnostic procedures (dermoscopy, punch biop-
sies) performed by the GPs; (3) the number of additional
(pre)malignant lesions found by the dermatologist; and (4)
the proportion of potentially unnecessary referrals.
The description of the lesion(s) was evaluated using the
generally accepted Dutch model to describe skin lesions (PRO-
VOKE), in which a skin disorder is supposed to be described
by mentioning seven characteristics (anatomical localization,
distribution, size, shape, border, colour and lesion morphol-
ogy). Firstly, the description of all seven characteristics were
separately analysed. In addition, the aggregated description
was analysed on completeness. For this, a ‘proper description’
was defined as the description of three or more characteristics
in the referral letter.
Potentially unnecessary referrals were lesions that probably
could have been treated in primary care, namely low-risk basal
cell carcinoma (BCC), low-risk Bowen disease (BD), actinic
keratosis (AK) and all benign diagnoses without any compli-
cating factors (see below) in accordance with the guideline of
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the Dutch College of General Practitioners and regional project
guidelines.10 A full overview of referral criteria is provided in
Appendix S1 (see Supporting Information).
Data were collected using both the referral letters and medi-
cal records (including histopathology reports). Data extraction
was performed by the same researcher in all cases in both
hospitals (E.M.). Data verification on accuracy and inconsisten-
cies was performed by a separate researcher (S.F.K.L.) in 10%
of the cases. In cases of inconsistency (019%) a consensus
meeting was planned and the full dataset was additionally
checked on this specific inconsistency.
Statistical analysis
A power analysis was performed to determine the minimum
number of referrals to be included to expect to find 40% cor-
rect diagnoses in the referral letters compared with the final
diagnoses made by dermatologists (as previously reported)5
and to consider a minimum difference of 10% in correct diag-
noses between the groups as a clinically relevant result with
power (1 – b) set at 080 and a = 005 (two-tailed). At least
404 referrals per cohort needed to be included. Because most,
but not all, variables analysed were included in the UHC, this
cohort was excluded in case a necessary variable was missing
for a specific analysis. Categorical and continuous variables
were described using numbers and percentages or mean and
standard deviation, respectively. Positive predictive values
(percentage of GP diagnoses that were in line with the final
diagnosis) were calculated per lesion type. To test for signifi-
cant differences between cohorts, a Chi-square test or inde-
pendent-samples Student’s t-test was applied for categorical
and continuous variables, respectively. To compare the effect
of the cohort on the likelihood for a correct diagnosis a
mixed-model logistic regression analysis was used, as this
takes the clustering of multiple referrals per GP into account.
As the specific GPs from the UHC are unknown, the UHC–TC
and UHC–UPC comparisons were performed with standard
logistic regression analysis. To give insight into the conse-
quences of taking the clustering effect into account, for the
UPC–TC comparison results from the standard as well as the
mixed-model logistic regression are presented. No imputation
of missing data was performed and only the available data per
variable were analysed, because the amount of missing data
was small. Data collection and statistical analysis were per-
formed by using the Statistical Package for Social Sciences
(SPSS) for Windows, version 250 (IBM Corp., Armonk, NY,
USA).
Ethics
Due to the nature of this study, evaluating an existing health-
care project, no formal medical ethical approval was necessary
according to Dutch law.
Results
Referral characteristics
A total of 1662 referral letters were included, of which 451
(271%) were in the TC, 476 (286%) were in the UPC and
735 (442%) were in the UHC (Figure 1). Referred patients
had a mean age of 597 ( 188) years and the majority were
women (n = 927; 558%). No statistically significant differ-
ences regarding sex and age distribution were detected
GPs in the Nijmegen area 
UNTRAINED HISTORICAL 
COHORT (UHC):
735 referral letters included 
(number of GPs not known)
Followed DOTP
Yes
PRESENT (2018–2019) PAST (2008–2010)
No
Nine trained GPs (4.6%) were 
excluded because although they 
followed the obligatory part of the 
training they did not consent to 
further participation
TRAINED COHORT (TC):
83 GPs (42.8%); 
451 referral letters included
UNTRAINED PRESENT COHORT (UPC):
102 GPs (52.6%);
476 referral letters included
Figure 1 Flowchart showing the inclusion of GPs and referral letters (same geographical area in both time periods). DOTP, dermato-oncological
training programme; GP, general practitioner.
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between the three cohorts. The most common reasons for
referral were lesions (clinically) diagnosed as BCC by GPs (n =
483; 291%), followed by melanocytic naevus (n = 309;
186%) and AK (n = 230; 138%), as shown in Table S1 (see
Supporting Information). In 272 (164%) referral letters, no
diagnosis was mentioned by the GP, and when comparing the
different cohorts this was significantly lower in the TC (n = 30;
67%) compared with the UPC (n = 65; 137%; P < 0001) and
the UHC (n = 177; 241%; P < 0001). A statistically signifi-
cant difference was also seen between the UPC and UHC
(P < 0001). For an overview per group, refer to Tables S2–4
(see Supporting Information). The median number of included
referral letters per GP was two (range 1–24) in the TC and UPC
(not known for UHC, because personalized GP data were
unavailable).
Lesion(s) description
Data on the description of each PROVOKE characteristic in the
different cohorts is shown in Table 1. A proper lesion(s)
description (at least three out of the seven PROVOKE charac-
teristics) was present more often in the TC (n = 198; 439%),
compared with the UPC (n = 167; 351%; P = 0006) and
UHC (n = 176; 239%; P < 0001), respectively. When com-
paring the control groups, the UPC contained a higher num-
ber of proper lesion(s) descriptions compared with the UHC
(n = 167; 351% vs. n = 176; 239%; P < 0001).
Diagnostic procedures performed by general practitioners
There were 595 lesions referred as BCC, squamous cell carci-
noma or BD (TC: n = 216, UPC: n = 170 and UHC: n = 209).
The percentage of punch biopsies taken was significantly
higher in the TC compared with the UPC (n = 67; 310% vs. n =
19; 112%; P < 0001) and UHC (n = 9; 43%) (P < 0001).
Also, a punch biopsy was performed more often in the UPC
compared with the UHC (P = 001). GPs mentioned the use of
dermoscopy in 113% (n = 51) of referrals in the TC, and 44%
(n = 21) in the UPC (P < 0001). The level of dermoscopy use
in the UHC was not known; therefore, comparison was not
possible.
Final diagnosis
The most common final diagnosis was BCC (n = 377; 227%),
followed by AK (n = 362; 218%), and melanocytic naevus (n
= 257; 155%) (Table S5; see Supporting Information). Of all
lesions diagnosed as (pre)malignancies with the exception of
AK (n = 544), a histopathological diagnosis was present in
976% (n = 531).
Agreement on diagnosis between the general practitioner
and dermatologist
As shown in Table 2, the percentage of correct primary
diagnoses by GPs was significantly higher in the TC
(n = 296/421; 703%) compared with the UPC (n = 231/
411; 562%; P < 0001) and the UHC (n = 288/558;
516%; P < 0001). There was no significant difference
between the UPC and UHC (P = 016). After exclusion of
all referrals containing a primary diagnosis which was
already histopathologically proven by the GP, the number of
correct primary diagnoses in the TC (n = 222/345; 643%)
remained significantly higher compared with both the UPC
(n = 203/383; 530%; P = 0002) and UHC (n = 276/548;
504%; P < 0001), while the UPC and UHC remained com-
parable (P = 043). Also, after correction for a potential
clustering effect based on the number of included referral
letters per GP using a mixed-model logistic regression analy-
sis (with GP as level, correct or incorrect diagnosis as out-
come and trained/untrained as determinant), comparable
outcomes on agreement on diagnoses between GP and der-
matologist were found (Table 2).
An overview of referral diagnoses and corresponding final
diagnoses for the TC, UPC and UHC is shown in Tables
S2–4 (see Supporting Information). In those cases where
the GP diagnosis was considered correct when the right
diagnosis was mentioned somewhere in the differential
diagnosis, 743% (n = 313) were correct in the TC, and
628% (n = 258) in the UPC (P < 0001). The full differ-
ential diagnosis was not known for the UHC; therefore,
comparison was not possible. Positive predictive values per
lesion type between the three cohorts are shown in
Table 3.
Additional (pre)malignant lesions found by the
dermatologist
In 159% (n = 264) of all referred patients, the dermatologist
found 406 additional (pre)malignant lesions (Table S6; see
Supporting Information). Additional lesions found mostly
included BCC (n = 196; 483%), followed by AK (n = 157;
387%) and BD (n = 26; 64%). The number of patients in
whom additional (pre)malignant lesions were found was com-
parable between the TC and UPC (n = 54; 120% vs. n = 64;
134%; P = 0502). This number was higher in the UHC (n =
146; 199%) compared with the TC (P < 0001) and UPC
(P = 0004).
Potentially unnecessary referrals
Table 4 shows the percentage of referrals that were potentially
unnecessary based on the final diagnosis. The TC had fewer
potentially unnecessary referrals (n = 283; 627%) than both
the UPC (n = 351; 737%; P < 0001) and the UHC (n = 553;
752%; P < 0001). No significant difference was detected
between the UPC and UHC (P = 056). Focusing on low-risk
BCC and low-risk BD specifically, no significant difference was
found between the TC and UPC (n = 19/134; 142% vs. n =
22/108; 203%; P = 020), as well as between the TC and
UHC (36/167; 216%; P = 010) and the UPC and UHC (P =
081).
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Effect of the dermato-oncological training programme
over time
No significant differences were found regarding proper
descriptions of lesion(s), agreement between the referral diag-
nosis (GP) and the final diagnosis (dermatologist) and poten-
tially unnecessary referrals comparing referrals from trained
GPs in the two different time periods (Table S7; see Support-
ing Information).
Effect of the additional live course(s)
A subanalysis within the TC between GPs who followed and
those who did not follow the additional live course(s) did not
show any significant differences on proper descriptions of
lesion(s), diagnostic accuracy and potentially unnecessary
referrals in this study (data not shown).
Discussion
The current study demonstrates that GPs who followed a
DOTP had better diagnostic skills and quality of referrals than
untrained GPs.
As shown here, trained GPs more often mentioned a diag-
nosis and proper description of lesion(s) in their referral let-
ters, performed more diagnostic procedures (dermoscopy and
punch biopsy) before referring a patient to a dermatologist,
and diagnosed skin lesions correctly more often (even after
correcting for diagnostic procedures performed). This might
Table 1 ‘PROVOKE’ description characteristics
Description characteristic TC, n (%) UPC, n (%) UHC, n (%) P-valuea
Anatomical localization 445 (987) 451 (947) 705 (959) 0001 / 0007 / 034
Distribution 7 (16) 2 (04) 9 (12) 008 / 063 / 015
Size 146 (324) 142 (298) 152 (207) 040 / < 0001 / < 0001
Shape 73 (162) 56 (118) 50 (68) 005 / < 0001 / 0002
Border 58 (129) 51 (107) 61 (83) 031 / 001 / 015
Colour 215 (477) 219 (460) 211 (287) 061 / < 0001 / < 0001
Morphology 128 (284) 92 (193) 127 (173) 0001 / < 0001 / 037
aTC vs. UPC/TC vs. UHC/UPC vs. UHC. TC, trained cohort; UHC, untrained historical cohort; UPC, untrained present cohort. Bold repre-
sents significant outcomes














OR 95% CI P-value
TC vs. UPC,
mixed-model LR
1882 1390–2584 < 0001
TC vs. UPC,
standard LR
1845 1387–2456 < 0001
TC vs. UHC,
standard LR




aReferral letters without a diagnosis mentioned were excluded
from this analysis. CI, confidence interval; LR, logistic regression;
OR, odds ratio; TC, trained cohort; UHC, untrained historical
cohort; UPC, untrained present cohort








BCC 679 522 484 0008 / < 0001 / 050
SCC 408 192 316 001 / 048 / 006
Melanoma
(in situ)
754 653 667 014 / 077 / 087
AK 600 500 735 070 / 079 / 025




778 667 579 043 / 0008 / 001
SK 765 714 821 022 / 067 / 022
aTC vs. UPC / TC vs. UHC / UPC vs. UHC. AK, actinic keratosis;
BCC, basal cell carcinoma; BD, Bowen disease; SCC, squamous
cell carcinoma; SK, seborrhoeic keratosis; TC, trained cohort;
UHC, untrained historical cohort; UPC, untrained present cohort.
Bold represents significant outcomes
Table 4 Potentially unnecessary referrals per cohort
Cohort Unnecessary referrals P-value
TC 283/451 (627%) < 0001a
UPC 351/476 (737%) 056b
UHC 553/735 (752%)
aP-value TC vs. UPC and UHC; bP-value UPC vs. UHC. TC,
trained cohort; UHC, untrained historical cohort; UPC, untrained
present cohort
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have all contributed to the lower number of potentially
unnecessary referrals found in the TC compared with both
untrained cohorts, which enhances optimal efficacy in SC care
and might eventually even lead to lower healthcare costs.17
These findings are generally in line with previous studies, also
describing an improvement in diagnostic skills for GPs who
followed a form of SC education,6–8 as well as performing
more diagnostic procedures themselves.18 However, because
the current study has a nonrandomized design, confirmation
of these findings in a randomized controlled trial would be
beneficial. Next to the improvement of efficacy in SC care,
lowering the number of potentially unnecessary referrals and
optimizing referral in case this is indicated (e.g. histopatho-
logical subtyping of a BCC by the GP before referral) might
improve the patient’s burden as well (e.g. by lowering the
hospital visits needed and enhancing the one-stop-shop con-
cept19). Furthermore, improved diagnostic skills of GPs might
enable the option to refer patients back to the GP for follow-
up after treatment of (high-risk) SC by the dermatologist at an
earlier time and thereby further optimize the limited capacity
of secondary SC care.
However, there still seems to be room for improvement.
Although the TC referred fewer patients with benign lesions and
AKs compared with both untrained cohorts, a major portion of
the reason(s) for referral in the TC still comprised these lesion
subtypes (456%). To enhance further improvement of SC care
efficacy, reducing the number of these types of referral is
desired and should be studied in more detail. In addition, no
significant difference was seen between the percentage of
patients with low-risk BCC and BD referred by the TC compared
with both untrained cohorts. This patient group comprises
another important portion of potentially unnecessary referrals in
the TC, even though transferring the care of patients with low-
risk SC to primary care was one of the main goals of the project
‘Suspicious Skin Lesions’. Another important finding was the
number of additional skin lesions found by dermatologists in
addition to the reason(s) for referral. Total-body skin examina-
tion (TBSE) comprises an essential part of dermato-oncological
care, because additional (pre)malignant skin lesions are often
found.20 This might be explained by fewer TBSEs performed by
GPs (although strongly encouraged in the DOTP) and/or previ-
ously shown lower diagnostic skills in diagnosing (pre)malig-
nant skin lesions compared with dermatologists.5 Lack of time
in primary care could be a factor contributing to the above-
mentioned points for improvement.9,21 Obviously, transfer of
SC care puts more pressure on primary care and a sufficient
amount of time, finances and healthcare providers seems essen-
tial to facilitate this. Another contributing factor could be that
some patients have a lack of trust in their GP to treat SC, and
therefore have a strong preference for referral to a dermatolo-
gist. Proper patient instruction on the roles of the GP and der-
matologist in SC care might assist in gaining a patient’s trust;22
therefore, we developed a patient leaflet on this topic which is
currently being used.
We did not see a difference in the main outcomes compar-
ing referrals from the two time periods (2 vs. 10 months after
training). Nevertheless, it would be interesting to find out if
these findings persist after a longer period of follow-up. In a
different study concerning the effect of a DOTP for GPs, only
a qshort-term effect was seen on the GPs’ competence, and
this effect was negligible after 12 months.23
Next to proper training, using obtained knowledge and
technical skills in daily practice on a regular basis seems essen-
tial to maintain quality, gain more experience and probably
lower the threshold to perform SC treatment in daily practice.
Therefore, having a GP with a special focus on SC care in a
group practice might help to maintain the effects of training
and further enhance treating more low-risk SCs in primary
care.24 Furthermore, a refresher course after a certain amount
of time might be helpful in maintaining high-quality SC care
as well. Another option could be to establish dedicated pri-
mary care SC centres, occupied by specially trained GPs, which
is already daily practice in some other countries with high SC
incidence rates (e.g. Australia).
A limitation of this study is a potential bias in the group
of trained GPs. GPs participating in the project could be
more interested and motivated in treating SC than other
GPs, and could therefore be more knowledgeable in SC
beforehand. A randomized controlled trial comparing trained
and untrained GPs could therefore be an interesting
approach for future research. Furthermore, it should be
noted that data regarding patients with SC treated in primary
care who are not referred to a dermatologist are missing in
this current study. More attention for primary SC care (with-
out referral to a dermatologist) in future research is there-
fore encouraged.
In conclusion, GPs who followed a dedicated DOTP had
better diagnostic skills and quality of referrals than untrained
GPs, leading to fewer potentially unnecessary referrals. This
might enhance a more efficient use of the limited capacity in
secondary dermatological care and consequently lead to lower
healthcare costs. Further optimization of SC care and addi-
tional transfer of care from dermatologists to GPs might be
accomplished by further development of educational pro-
grammes and by appointing specially trained GPs.
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